US Stock MarketDetailed Quotes
TARA Protara Therapeutics
- 2.940
- +0.340+13.08%
Close Nov 26 16:00 ET
- 2.850
- -0.090-3.06%
Post 20:01 ET
60.65MMarket Cap-1113P/E (TTM)
3.000High2.600Low289.14KVolume2.660Open2.600Pre Close818.29KTurnover1.87%Turnover RatioLossP/E (Static)20.63MShares5.24052wk High0.74P/B45.51MFloat Cap1.35052wk Low--Dividend TTM15.48MShs Float800.000Historical High--Div YieldTTM15.39%Amplitude1.040Historical Low2.830Avg Price1Lot Size
Protara Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 15.23%12.33M | -12.18%10.66M | 21.77%11.85M | 16.16%43.61M | 10.50%11.04M | 34.19%10.7M | 39.46%12.14M | -10.50%9.73M | -20.94%37.55M | -2.87%9.99M |
| Selling and administrative expenses | -4.95%4.26M | -12.65%4.27M | -10.59%4.1M | -10.19%18.62M | -6.86%4.66M | -0.58%4.48M | -12.95%4.89M | -18.13%4.59M | -21.45%20.74M | -19.55%5M |
| -General and administrative expense | -4.95%4.26M | -12.65%4.27M | -10.59%4.1M | -10.19%18.62M | -6.86%4.66M | -0.58%4.48M | -12.95%4.89M | -18.13%4.59M | -21.45%20.74M | -19.55%5M |
| Research and development costs | 29.78%8.07M | -11.87%6.39M | 50.65%7.75M | 48.67%24.99M | 27.90%6.38M | 79.40%6.22M | 134.99%7.25M | -2.39%5.14M | -20.30%16.81M | 22.64%4.99M |
| Operating profit | -15.23%-12.33M | 12.18%-10.66M | -21.77%-11.85M | -16.16%-43.61M | -10.50%-11.04M | -34.19%-10.7M | -39.46%-12.14M | 10.50%-9.73M | 20.94%-37.55M | 2.87%-9.99M |
| Net non-operating interest income expense | 31.62%1.1M | 35.04%1.14M | 8.73%747K | 191.03%3.18M | 55.05%814K | 196.11%838K | 407.23%842K | 477.31%687K | 361.18%1.09M | 789.83%525K |
| Non-operating interest income | 31.62%1.1M | 35.04%1.14M | 8.73%747K | 42.65%3.18M | 28.80%814K | 50.45%838K | 64.45%842K | 29.87%687K | 12.97%2.23M | 22.48%632K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -34.54%1.14M | -76.59%107K |
| Other net income (expense) | 300.00%8K | 175.00%11K | 9K | 100.04%12K | 6K | 2K | 4K | -29.5M | ||
| Gain on sale of security | 300.00%8K | 175.00%11K | --9K | -29.41%12K | --6K | --2K | --4K | ---- | --17K | ---- |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---29.52M | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --29.52M | ---- |
| Income before tax | -13.78%-11.22M | 15.77%-9.51M | -22.66%-11.1M | 38.71%-40.42M | 73.77%-10.22M | -28.20%-9.86M | -32.26%-11.29M | 15.90%-9.05M | -39.58%-65.95M | -280.98%-38.97M |
| Income tax | ||||||||||
| Net income | -13.78%-11.22M | 15.77%-9.51M | -22.66%-11.1M | 38.71%-40.42M | 73.77%-10.22M | -28.20%-9.86M | -32.26%-11.29M | 15.90%-9.05M | -39.58%-65.95M | -280.98%-38.97M |
| Net income continuous Operations | -13.78%-11.22M | 15.77%-9.51M | -22.66%-11.1M | 38.71%-40.42M | 73.77%-10.22M | -28.20%-9.86M | -32.26%-11.29M | 15.90%-9.05M | -39.58%-65.95M | -280.98%-38.97M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -13.78%-11.22M | 15.77%-9.51M | -22.66%-11.1M | 38.71%-40.42M | 73.77%-10.22M | -28.20%-9.86M | -32.26%-11.29M | 15.90%-9.05M | -39.58%-65.95M | -280.98%-38.97M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -13.78%-11.22M | 15.77%-9.51M | -22.66%-11.1M | 38.71%-40.42M | 73.77%-10.22M | -28.20%-9.86M | -32.26%-11.29M | 15.90%-9.05M | -39.58%-65.95M | -280.98%-38.97M |
| Basic earnings per share | 42.53%-0.5 | 55.00%-0.45 | -21.25%-0.97 | 39.08%-3.57 | 73.99%-0.9 | -27.94%-0.87 | -31.58%-1 | 16.67%-0.8 | -39.19%-5.86 | -280.22%-3.46 |
| Diluted earnings per share | 42.53%-0.5 | 55.00%-0.45 | -21.25%-0.97 | 39.08%-3.57 | 73.99%-0.9 | -27.94%-0.87 | -31.58%-1 | 16.67%-0.8 | -39.19%-5.86 | -280.22%-3.46 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data